PFIZER INC: Drug Recall
Recall #D-0590-2025 · 08/04/2025
Class II: Risk
Recall Details
- Recall Number
- D-0590-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- PFIZER INC
- Status
- Ongoing
- Date Initiated
- 08/04/2025
- Location
- New York, NY, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 49,620 vials
Reason for Recall
Lack of Assurance of Sterility.
Product Description
Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4933-05. Case: NDC 0409-4933-10.
Distribution Pattern
U.S. Nationwide
Other Recalls by PFIZER INC
- Class II: Risk 08/04/2025
- Class II: Risk 07/10/2025
- Class II: Risk 07/10/2025
- Class II: Risk 05/28/2025
- Class II: Risk 05/20/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.